|

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

RECRUITINGSponsored by Lahey Clinic
Actively Recruiting
SponsorLahey Clinic
Started2002-09
Est. completion2028-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT00872495

Summary

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up)
* Control Group: No known evidence of bladder cancer-one urine sample
* \> than 18 years of age

Exclusion Criteria:

* \< than 18 years of age

Conditions4

Bladder NeoplasmsCancerUrinary Bladder CancerUrothelial Cancer

Locations1 site

Lahey Clinic, Inc.
Burlington, Massachusetts, 01805
Arthur Mourtzinos, M.D.

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.